Therapies Offered at Residential Addiction Treatment Programs in the United States

This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2020-08, Vol.324 (8), p.804-806
Hauptverfasser:	Beetham, Tamara, Saloner, Brendan, Gaye, Marema, Wakeman, Sarah E, Frank, Richard G, Barnett, Michael L
Format:	Artikel
Sprache:	eng
Schlagworte:	Addictions Analgesics, Opioid - therapeutic use Behavior Therapy Behavior, Addictive - therapy Buprenorphine Drug abuse Drug addiction Health Care Surveys Humans Letter Letters Methadone Naloxone Narcotics Opioid-Related Disorders - drug therapy Opioid-Related Disorders - rehabilitation Opioid-Related Disorders - therapy Opioids Research Letter Residential Treatment Substance abuse treatment United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.2020.8969